Abraham Teunissen | Immunology | Best Researcher Award

Dr. Abraham Teunissen | Immunology | Best Researcher Award

Dr. Abraham Teunissen, Icahn school of medicine, United States.

Dr. Abraham J. P. Teunissen 🎓 is an Assistant Professor at the Biomedical Engineering and Imaging Institute, Icahn School of Medicine, New York 🗽. He leads groundbreaking research in nanomedicine, radiochemistry, and immunotherapy 🧬. With a Ph.D. in Molecular Engineering, he has authored high-impact studies and holds key patents. Dr. Teunissen mentors future scientists 👨‍🔬👩‍🔬 and champions diversity and inclusion. His work on trained immunity and advanced imaging technologies is shaping the future of personalized medicine 🌟.

🌟 Professional Profile

🎓Early Academic Pursuits 

Abraham J. P. Teunissen, Ph.D., embarked on his academic journey at Fontys University of Applied Science, earning a B.ASc in Organic Chemistry in 2011, where he developed supramolecular polymers for improved hemodialysis. He continued at Eindhoven University of Technology, securing an M.Sc. in Molecular Engineering (2013) and completing a Ph.D. (2017) focused on competing interactions in chemical reaction networks. His early research on biomimetic systems and chemical networks laid the foundation for a distinguished career in biomedical sciences.

🏢Professional Endeavors 

Dr. Teunissen’s professional journey showcases a trajectory of growth and leadership. He held appointments at the prestigious Icahn School of Medicine at Mount Sinai, progressing from Postdoctoral Scientist (2017) to Instructor (2019), and ultimately to Assistant Professor (2022). He also serves as the Director of Radiochemistry at the Biomedical Engineering and Imaging Institute. Beyond academia, he consulted for Trained Therapeutix Discovery, driving translational innovation from 2019 to 2021.

🔬Contributions and Research Focus On Immunology 

Dr. Teunissen has made notable contributions to nanomedicine, immunology, and molecular imaging. His research lab develops novel nanotherapies and imaging probes to modulate and monitor the immune system in various diseases — including cancer, cardiovascular disease, diabetes, and organ transplantation. His team’s work spans small and large animal models, advancing therapeutic strategies with clinical relevance. His radiochemistry facility supports diverse collaborations, innovating nanoparticle tracking and immune monitoring using immuno-PET technology.

🌎Impact and Influence 

The outcomes of Dr. Teunissen’s research have wide-reaching impacts. His lab’s pioneering work on trained immunity modulation has driven forward collaborations, clinical translation efforts, and even the founding of a biotech company, Trained Therapeutix Discovery. His immuno-PET technologies enhance understanding of disease mechanisms and inform therapeutic interventions, demonstrating translational significance from bench to bedside.

📚Academic Cites and High-Impact Publications 

Dr. Teunissen’s work has appeared in leading journals such as Cell, Nature Biomedical Engineering, Nature Nanotechnology, and Science Translational Medicine. His high citation count reflects the significance of his research, especially in trained immunity, nanomedicine, and molecular imaging fields. These citations highlight his contributions to both fundamental science and applied biomedical research.

🏆Awards and Honors 

While specific individual awards were not detailed, Dr. Teunissen’s achievements include serving as an ad-hoc NIH and American Cancer Society grant reviewer, organizing major scientific symposia, and designing graduate-level coursework. His leadership roles — like incident commander and scientific advisory organizer — reflect high institutional trust and professional recognition.

🔮Legacy and Future Contributions 

Dr. Teunissen’s legacy is rooted in scientific excellence, mentorship, and innovation. With an active lab mentoring a diverse group of postdocs, graduate, and premedical students, he is shaping the next generation of biomedical engineers and nanomedicine scientists. His future contributions are expected to further bridge fundamental science and clinical application, aiming to improve therapeutic outcomes for major diseases through immune modulation and advanced molecular imaging. His strong commitment to diversity, inclusion, and education ensures a lasting positive impact on both science and society.

📚Publications Top Notes

  • Development of Methods for the Determination of pKa Values
    📰 Analytical Chemistry Insights | 📑 483 citations | 📅 2013

  • Investigating Supramolecular Systems Using Förster Resonance Energy Transfer
    📰 Chemical Society Reviews | 📑 159 citations | 📅 2018

  • Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition
    📰 Cell | 📑 145 citations | 📅 2020

  • Efficacy and Safety Assessment of a TRAF6-Targeted Nanoimmunotherapy in Atherosclerotic Mice and Non-Human Primates
    📰 Nature Biomedical Engineering | 📑 128 citations | 📅 2018

  • End Groups of Functionalized Siloxane Oligomers Direct Block-Copolymeric or Liquid-Crystalline Self-Assembly Behavior
    📰 Journal of the American Chemical Society | 📑 110 citations | 📅 2016

  • Tumor Targeting by αvβ3-Integrin-Specific Lipid Nanoparticles Occurs via Phagocyte Hitchhiking
    📰 ACS Nano | 📑 93 citations | 📅 2020

  • Directing the Self‐Assembly Behaviour of Porphyrin‐Based Supramolecular Systems
    📰 Chemistry – A European Journal | 📑 82 citations | 📅 2017

  • Imaging-Assisted Nanoimmunotherapy for Atherosclerosis in Multiple Species
    📰 Science Translational Medicine | 📑 68 citations | 📅 2019

  • Prosaposin Mediates Inflammation in Atherosclerosis
    📰 Science Translational Medicine | 📑 65 citations | 📅 2021

  • Nuclear Imaging Approaches Facilitating Nanomedicine Translation
    📰 Advanced Drug Delivery Reviews | 📑 63 citations | 📅 2020

  • Probing Myeloid Cell Dynamics in Ischaemic Heart Disease by Nanotracer Hot-Spot Imaging
    📰 Nature Nanotechnology | 📑 61 citations | 📅 2020

  • Mechanically Induced Gelation of a Kinetically Trapped Supramolecular Polymer
    📰 Macromolecules | 📑 52 citations | 📅 2014

  • Imaging Cardiovascular and Lung Macrophages with the Positron Emission Tomography Sensor 64Cu-Macrin in Mice, Rabbits, and Pigs
    📰 Circulation: Cardiovascular Imaging | 📑 44 citations | 📅 2020

  • Resolving Sepsis-Induced Immunoparalysis via Trained Immunity by Targeting Interleukin-4 to Myeloid Cells
    📰 Nature Biomedical Engineering | 📑 37 citations | 📅 2023

  • A Modular Approach Toward Producing Nanotherapeutics Targeting the Innate Immune System
    📰 Science Advances | 📑 35 citations | 📅 2021

  • An Iterative Sparse Deconvolution Method for Simultaneous Multicolor 19F‐MRI of Multiple Contrast Agents
    📰 Magnetic Resonance in Medicine | 📑 30 citations | 📅 2020

 

Agustina Costa | Immunology and Microbiology | Best Researcher Award

Dr. Agustina Costa | Immunology and Microbiology | Best Researcher Award

Dr. Agustina Costa, Anlis-Malbran, Argentina.

Agustina Costa is a highly accomplished biologist and researcher specializing in microbiology and biochemistry. She earned her PhD in Pharmacy and Biochemistry from the University of Buenos Aires in 2023, where she achieved an outstanding grade for her thesis focused on detecting β-lactamases in Enterobacterales using MALDI-TOF mass spectrometry. Agustina also holds a Licenciatura in Biological Sciences from Universidad Favaloro and has over 17 years of professional experience in renowned institutions like INEI-ANLIS-MALBRAN and Hospital Alemán. Her research expertise is showcased in numerous high-impact publications, particularly in the fields of microbial diagnostics and antimicrobial resistance. She has presented her findings at over 15 national and international conferences and has contributed to various research projects funded by ANPCyT and CONICET. Fluent in English and skilled in advanced genomic analysis, Agustina is dedicated to advancing the field of microbiology and improving public health through innovative research.

Professional Profile:

Scopus

Summary of Suitability for Best Researcher Award

Agustina Costa, PhD in Pharmacy and Biochemistry from the University of Buenos Aires, demonstrates exceptional expertise in microbiology with a specialized focus on using MALDI-TOF MS for the rapid detection of β-lactamase-producing Enterobacterales. Her academic background, complemented by a Licenciatura in Biological Sciences, reflects a strong foundation in microbial research and diagnostic methodologies. Throughout her career, she has been affiliated with prestigious institutions, including INEI-ANLIS-MALBRAN and Hospital Alemán, where she honed her skills in microbiology and molecular biology.

🎓 Education:

Agustina Costa has a strong academic foundation, highlighted by a PhD in Pharmacy and Biochemistry from the University of Buenos Aires (2023), where she achieved an “Outstanding” grade for her thesis on β-lactamase detection using MALDI-TOF mass spectrometry. Her academic journey began with a Licenciatura in Biological Sciences from Universidad Favaloro, complemented by technical training in microbiology. This blend of theoretical knowledge and practical skills demonstrates her commitment to scientific excellence and specialized expertise in microbiology and biochemistry

💼Professional Experience:

Agustina Costa has over 17 years of diverse experience in microbiology, working in prominent institutions such as INEI-ANLIS-MALBRAN and Hospital Alemán. Currently, she serves as a professional in the Enterobacteria Service, showcasing her hands-on expertise in microbiological research and diagnostics. Her previous roles span from molecular biology techniques to quality control in microbiology, reflecting her comprehensive knowledge in clinical and laboratory settings

🌍 Publications and Research Contributions

Agustina Costa has an impressive portfolio of publications, including multiple research articles in high-impact journals such as PathogensFrontiers in Cellular and Infection Microbiology, and Journal of Microbiological Methods. Her work primarily focuses on the use of MALDI-TOF MS for rapid microbial identification and antimicrobial resistance detection, highlighting her contributions to advancing diagnostic microbiology. Notably, her research on KPC detection and the genomic characterization of resistant plasmids demonstrates her commitment to addressing critical challenges in public health.

🥇Award and Honors:

Agustina Costa has been recognized for her exceptional contributions to microbiology and biochemistry through multiple awards and honors. She has presented her groundbreaking research at over 15 prestigious national and international conferences, including ASM Microbe, SADI-Argentina, and SADEBAC-Argentina, where she often served as the first author. Agustina has also secured competitive research grants from ANPCyT and CONICET, reflecting her ability to lead impactful scientific projects. Her innovative work in microbial diagnostics, particularly in using MALDI-TOF MS for rapid pathogen detection, has earned her accolades within the scientific community, solidifying her reputation as a leader in the field of microbiology.

Conclusion:

Agustina Costa stands out as a highly skilled researcher with a robust background in microbiology and biochemistry. Her extensive academic achievements, highlighted by a PhD with distinction from the University of Buenos Aires, are complemented by over 17 years of professional experience in prominent research institutions. Agustina’s impressive portfolio of high-impact publications, particularly in antimicrobial resistance and microbial diagnostics using MALDI-TOF MS, demonstrates her expertise and contributions to public health. Her active engagement in scientific conferences and successful grant applications further solidify her reputation as a leading researcher. Overall, Agustina’s dedication and accomplishments make her a strong contender for the Research for Best Researcher

📖 Publication Top Notes

  1. MALDI-TOF MS-Based KPC Direct Detection from Patients’ Positive Blood Culture Bottles, Short-Term Cultures, and Colonies at the Hospital | 3 citations 📊

  2. Co-Occurrence of NDM-5 and RmtB in a Clinical Isolate of Escherichia coli Belonging to CC354 in Latin America12 citations 📊

  3. Bacteremia and Sepsis by Arcanobacterium haemolyticum in a Young Immunocompetent Patient4 citations 📊

  4. MALDI-TOF MS Based Procedure to Detect KPC-2 Directly from Positive Blood Culture Bottles and Colonies |33 citations 📊